Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)); Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography
Publication Month: Jul 2020 | Report Code: TIPRE00008219 | No. of Pages: 149 | Category: Pharmaceuticals | Status: Published
The allergy immunotherapies market was valued at US$ 1,819.18 million in 2019 and is projected to reach US$ 4,185.89 million by 2027; it is expected to grow at a CAGR of 11.1% from 2020 to 2027.
Allergy immunotherapy, also called desensitization or hypo-sensitization, is a medical treatment focused on several types of allergies. There is a growth in the prevalence of allergies, and conventional treatment interventions, such as pharmacotherapy, have often been found incompetent. Consequently, allergy immunotherapy is growing popularity for curing several types of allergies by increasing immunological tolerance and changing the course of the disease. The allergy immunotherapies market is expected to grow owing to key driving factors such as the increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations. However, drawbacks associated with the use of allergy immunotherapies and regulatory variations across regions is likely to hamper the growth of the market during the forecast period.
Lucrative Regions for Allergy Immunotherapies Market
Get more information on this report :
Market Insights
Growing Prevalence of Allergic Disorders
Allergic disorders are the most common problems addressed by primary care physicians and pediatricians; more than 25% of the population in developed countries suffers from allergies. Allergies encompass a spectrum of disorders that are characterized by the development of an overactive immune response to an allergen, resulting in Th2 polarized cytokine response to the allergen and the production of an IgE antibody response.
The growing prevalence of allergic disorders demands allergy immunotherapy, which is a safe and effective treatment against allergens such as pollen, insect molds, and animals, as well as for allergic asthma. In the recent report of the National Health and Nutrition Examination Survey, 54% of the population had positive test responses to one or more allergens. According to the American Academy of Allergy, Asthma & Immunology, allergic rhinitis affects 10–30% of the population, and adverse drug reactions may affect up to 10% of the global population, and nearly 20% of hospitalized patients. As per the data of the National Center for Health Statistics survey carried out in 2018, the number of reported respiratory allergies, food allergies, and skin allergies in the past 12 months was 7.1 million, 4.8 million, and 9.2 million, respectively.
Immunotherapy is a preventive treatment for allergic reactions to substances such as house dust mites, bee venom, and grass pollens. Immunotherapy involves a gradual increase in doses of the allergen or substance to which the patient is allergic. The incremental doses of the allergen cause the immune system to become less sensitive to the substance, probably by inducing the production of a "blocking" antibody; this lowers the allergic symptoms when the substance is encountered in the future. Immunotherapy also reduces the inflammation that characterizes asthma and rhinitis. Allergic disorders are mostly treated with immunotherapy; thus, the growing prevalence of allergic diseases drives the growth of the market
.
Treatment -Based Insights
Global allergy immunotherapies market, based on treatment is segmented into Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT). In 2019, the Subcutaneous Immunotherapy (SCIT) segment held the largest share of the market, by Treatment. However, the Sublingual Immunotherapy (SLIT) segment is expected to grow at the fastest rate during the forecast period.
Global Allergy Immunotherapies Market, by Treatment– 2019 & 2027
Get more information on this report :
Allergy Type-Based Insights
The global allergy immunotherapies market, based on allergy type was segmented into allergic rhinitis, asthma, food allergy, venom allergy, and others. The allergic rhinitis segment held the highest share of the allergy immunotherapies market in 2019, by allergy type. Moreover, the same segment is anticipated to witness growth at a significant rate during the forecast period, 2020 to 2027.
Distribution Channel -Based Insights
Global allergy immunotherapies market, based on distribution channel is segmented into, hospital pharmacy, retail pharmacy and online pharmacy. In 2019, the hospital pharmacy settings segment held the largest share of the market, by Distribution channel. Moreover, the same pharmacy segment is expected to grow at the fastest rate during the forecast period
Product launches and expansion strategy are commonly adopted by companies to expand their footprint worldwide and meet the growing demand. These strategies are commonly adopted by the market players in order to expand its product portfolio.
The market players operating in the allergy immunotherapies market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.
By Treatment
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
By Allergy Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
Asia Pacific(APAC)
- China
- India
- South Korea
- Japan
- Australia
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
South America (SAM)
- Brazil
- Argentina
Company Profiles
- ALK-Abelló A/S
- AIMMUNE THERAPEUTICS, INC.
- LETIPharma
- Stallergenes Greer
- HAL Allergy B.V
- Johnson and Johnson Services, Inc.
- Anergis
- DBV Technologies
- Dermapharm Holding
- Allergy Therapeutics
Frequently Asked Questions
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Allergy Immunotherapies Market – By Treatment
1.3.2 Allergy Immunotherapies Market – By Allergy Type
1.3.3 Allergy Immunotherapies Market – By Distribution Channel
1.3.4 Allergy Immunotherapies Market – By Geography
2. Allergy Immunotherapies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Allergy Immunotherapies Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia-Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinion
5. Allergy immunotherapies Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Allergic Disorders
5.1.2 Technological Advancements in Sublingual Dosage Formulations
5.2 Key Market Restraint
5.2.1 Drawbacks Associated with the Use of Allergy Immunotherapy
5.2.2 Regulatory Variations Across Regions
5.3 Key Market Opportunities
5.3.1 Presence of Strong Product Pipeline
5.4 Future Trends
5.4.1 Increasing FDA Approvals for Drugs
5.5 Impact Analysis
6. Allergy Immunotherapies Market – Global Analysis
6.1 Global Allergy Immunotherapies Market Revenue Forecast And Analysis
6.2 Global Allergy immunotherapies market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Allergy Immunotherapies Market Analysis– by Treatment
7.1 Overview
7.2 Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)
7.3 Subcutaneous Immunotherapy (SCIT)
7.3.1 Overview
7.3.2 Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
7.4 Sublingual Immunotherapy (SLIT)
7.4.1 Overview
7.4.2 Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
8. Allergy Immunotherapies Market Analysis– by Allergy Type
8.1 Overview
8.2 Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)
8.3 Allergic Rhinitis
8.3.1 Overview
8.3.2 Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Asthma
8.4.1 Overview
8.4.2 Asthma Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Food Allergy
8.5.1 Overview
8.5.2 Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.6 Venom Allergy
8.6.1 Overview
8.6.2 Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.7 Other Allergies
8.7.1 Overview
8.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)
9. Allergy Immunotherapies Market Analysis– by Distribution Channel
9.1 Overview
9.2 Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
10. Allergy Immunotherapies Market Analysis And Forecasts To 2027 – Geographical Analysis
10.1 North America: Allergy immunotherapies market
10.1.1 Overview
10.1.2 North America : Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.1.3 North America: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
10.1.7 US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1 Europe: Allergy Immunotherapies Market
10.1.1 Overview
10.1.2 Europe: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 Europe: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.4 Europe: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 Europe: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 Europe: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.1.7 Germany: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Germany: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Germany: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Germany: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Germany: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 France: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 France: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 France: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 France: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 France: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 UK: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 UK: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 UK: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 UK: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 UK: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.10 Italy: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Italy: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Italy: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.10.3 Italy: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.10.4 Italy: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.11 Spain: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Spain: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Spain: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Spain: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Spain: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2 Asia-Pacific: Allergy Immunotherapies Market
10.2.1 Overview
10.2.2 Asia-Pacific: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Asia-Pacific Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.4 Asia-Pacific Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.5 Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.6 Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.2.7 China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Millkion)
10.2.7.2 China Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.7.3 China Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.7.4 China Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.8 Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 Japan Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.8.3 Japan Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.8.4 Japan Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.9 India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 India Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.9.3 India Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.9.4 India Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.10 South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 South Korea Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.10.3 South Korea Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.10.4 South Korea Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.11 Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Australia Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Australia Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Australia Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3 Middle East & Africa: Allergy immunotherapies market
10.3.1 Overview
10.3.2 Middle East & Africa: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.3.3 Middle East and Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.3.4 Middle East and Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.3.5 Middle East and Africa Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.6 Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.3.7 Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 Saudi Arabia Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.3.7.3 Saudi Arabia Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.3.7.4 Saudi Arabia Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.8 UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 UAE Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.3.8.3 UAE Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.3.8.4 UAE Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.9 South Africa: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 South Africa: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 South Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.3.9.3 South Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.3.9.4 South Africa Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4 South and Central America: Allergy immunotherapies market
10.4.1 Overview
10.4.2 South and Central America: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.4.3 South and Central America Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.4.4 South and Central America Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.4.5 South and Central America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.6 South and Central America: Allergy immunotherapies Market, by Country, 2019 & 2027 (%)
10.4.7 Brazil: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Brazil: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Brazil Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Brazil Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Brazil Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.8 Argentina: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 Argentina: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 Argentina Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.4.8.3 Argentina Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.4.8.4 Argentina Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Allergy Immunotherapies Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Allergy Immunotherapies Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 ALK-Abelló A/S
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 AIMMUNE THERAPEUTICS, INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 LETIPharma
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Stallergenes Greer
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 HAL Allergy B.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Johnson and Johnson Services, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Anergis
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 DBV Technologies
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Dermapharm Holding
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Allergy Therapeutics
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 4. US Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 5. US Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 6. US Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Europe: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 14. Europe: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Europe: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 16. Germany: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 17. Germany: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Germany: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 19. France: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 20. France: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 21. France: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 22. UK: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 23. UK: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 24. UK: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 25. Italy: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 26. Italy: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 27. Italy: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 28. Spain: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 29. Spain: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 30. Spain: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 31. Asia-Pacific Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 32. Asia-Pacific Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 33. Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 34. China Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 35. China Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 36. China Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 37. Japan Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 38. Japan Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 39. Japan Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 40. India Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 41. India Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 42. India Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 43. South Korea Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 44. South Korea Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 45. South Korea Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 46. Australia Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 47. Australia Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 48. Australia Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 49. Middle East and Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 50. Middle East and Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 51. Middle East and Africa Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 52. Saudi Arabia Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 53. Saudi Arabia Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 54. Saudi Arabia Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 55. UAE Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 56. UAE Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 57. UAE Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 58. South Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 59. South Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 60. South Africa Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 61. South and Central America Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 62. South and Central America Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 63. South and Central America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 64. Brazil Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 65. Brazil Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 66. Brazil Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 67. Argentina Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 68. Argentina Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 69. Argentina Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 1. Organic Developments Done By Companies
Table 2. Inorganic Developments Done By Companies
Table 3. Glossary of Terms, Allergy Immunotherapies Market
LIST OF FIGURES
Figure 1. Allergy Immunotherapies Market Segmentation
Figure 2. Allergy Immunotherapies Market – By Geography
Figure 3. Global Allergy Immunotherapies Market Overview
Figure 4. Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market
Figure 5. Asia-Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Global Allergy Immunotherapies Market, By Geography (US$ Million)
Figure 7. Global Allergy Immunotherapies Market- Leading Country Markets (US$ Million)
Figure 8. Global Allergy Immunotherapies Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia-Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Allergy immunotherapies Market Impact Analysis of Driver and Restraints
Figure 15. Global Allergy Immunotherapies Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Allergy Immunotherapies Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning of Key Players
Figure 18. Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)
Figure 19. Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 20. Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 21. Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)
Figure 22. Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
Figure 23. Asthma Market Revenue and Forecasts to 2027 (US$ Million)
Figure 24. Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 25. Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 26. Others Market Revenue and Forecasts to 2027 (US$ Million)
Figure 27. Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)
Figure 28. Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 29. Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 30. Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 31. North America: Allergy immunotherapies market, by Key Country – Revenue (2019) (USD Million)
Figure 32. North America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 33. North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
Figure 34. US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Mexico: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Europe: Allergy Immunotherapies Market, by Key Country – Revenue (2019) (USD Million)
Figure 38. Europe: Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)
Figure 39. Europe: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 40. Germany: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. France: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. UK: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Italy: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. Spain: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Asia-Pacific: Allergy Immunotherapies Market, by Key Country – Revenue (2019) (USD Million)
Figure 46. Asia-Pacific Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)
Figure 47. Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 48. China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. Middle East & Africa: Allergy immunotherapies market, by Key Country – Revenue (2019) (USD Million)
Figure 54. Middle East & Africa Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 55. Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 56. Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 57. UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 58. South Africa: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. South and Central America: Allergy immunotherapies market, by Key Country – Revenue (2019) (USD Million)
Figure 60. South and Central America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 61. South and Central America: Allergy immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 62. Brazil: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 63. Argentina: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. Impact of COVID-19 Pandemic on allergy immunotherapies market in North American Countries
Figure 65. Impact of COVID-19 Pandemic on allergy immunotherapies market in European Countries
Figure 66. Impact of COVID-19 Pandemic on allergy immunotherapies market in Asia Pacific Countries
Figure 67. Impact of COVID-19 Pandemic on allergy immunotherapies market in Rest of the World
Figure 68. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Allergy Immunotherapies Market
- ALK-Abelló A/S
- AIMMUNE THERAPEUTICS, INC.
- LETIPharma
- Stallergenes Greer
- HAL Allergy B.V.
- Johnson and Johnson Services, Inc.
- Anergis
- DBV Technologies
- Dermapharm Holding
- Allergy Therapeutics
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the allergy immunotherapies market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global allergy immunotherapies market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
-
$3000
-
$4550 $3640
-
$6550 $5240
-
$8550 $6840
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount